Neuromod prepares for global commercialisation of Lenire tinnitus treatment

Neuromod Devices, the Irish medical technology company specialising in non-invasive neuromodulation technologies, has provided an update on organisational and leadership growth in preparation for European commercialisation and US regulatory clearance application. Following the completion of two of the largest clinical trials ever conducted in tinnitus; including 517 participants, the Company is now advancing towards initial … Continue reading Neuromod prepares for global commercialisation of Lenire tinnitus treatment